Logo image of NUW

NUVEEN AMT-FREE MUNI VAL (NUW) Stock Price, Quote, News and Overview

NYSE:NUW - New York Stock Exchange, Inc. - US6706951059 - Currency: USD

13.68  -0.03 (-0.22%)

Fundamental Rating

2

Overall NUW gets a fundamental rating of 2 out of 10. We evaluated NUW against 0 industry peers in the Unkown industry. NUW may be in some trouble as it scores bad on both profitability and health. NUW has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NUW was profitable.
NUW had positive earnings in 4 of the past 5 years.
NUW had a negative operating cash flow in each of the past 5 years.
NUW Yearly Net Income VS EBIT VS OCF VS FCFNUW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

1.2 Ratios

The 3 year average ROIC (2.43%) for NUW is below the current ROIC(2.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.35%
ROE 3.39%
ROIC 2.76%
ROA(3y)-2.87%
ROA(5y)0.77%
ROE(3y)-2.91%
ROE(5y)0.78%
ROIC(3y)2.43%
ROIC(5y)2.46%
NUW Yearly ROA, ROE, ROICNUW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

NUW's Profit Margin has improved in the last couple of years.
NUW's Operating Margin has been stable in the last couple of years.
In the last couple of years the Gross Margin of NUW has remained more or less at the same level.
Industry RankSector Rank
OM 84.12%
PM (TTM) 80.85%
GM 84.9%
OM growth 3Y1.21%
OM growth 5Y0%
PM growth 3Y7.8%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-0.16%
NUW Yearly Profit, Operating, Gross MarginsNUW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 200 -200 -400

More info and screens

3

2. Health

2.1 Basic Checks

NUW has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NUW has more shares outstanding
Compared to 1 year ago, NUW has about the same debt to assets ratio.
NUW Yearly Shares OutstandingNUW Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M
NUW Yearly Total Debt VS Total AssetsNUW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

NUW has an Altman-Z score of 50.28. This indicates that NUW is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that NUW is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 50.28
ROIC/WACCN/A
WACCN/A
NUW Yearly LT Debt VS Equity VS FCFNUW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.3 Liquidity

NUW has a Current Ratio of 1.93. This is a normal value and indicates that NUW is financially healthy and should not expect problems in meeting its short term obligations.
NUW has a Quick Ratio of 1.93. This is a normal value and indicates that NUW is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
NUW Yearly Current Assets VS Current LiabilitesNUW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

NUW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.49%, which is quite impressive.
NUW shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.23% yearly.
The Revenue has been growing slightly by 5.77% in the past year.
The Revenue has been decreasing by -3.52% on average over the past years.
EPS 1Y (TTM)119.49%
EPS 3Y7.23%
EPS 5YN/A
EPS Q2Q%22.08%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y4.79%
Revenue growth 5Y-3.52%
Sales Q2Q%5.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NUW Yearly Revenue VS EstimatesNUW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.50, which means the current valuation is very expensive for NUW.
The average S&P500 Price/Earnings ratio is at 28.87. NUW is around the same levels.
Industry RankSector Rank
PE 28.5
Fwd PE N/A
NUW Price Earnings VS Forward Price EarningsNUW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUW Per share dataNUW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

NUW has a Yearly Dividend Yield of 3.72%. Purely for dividend investing, there may be better candidates out there.
NUW's Dividend Yield is rather good when compared to the S&P500 average which is at 2.46.
Industry RankSector Rank
Dividend Yield 3.72%

5.2 History

NUW has paid a dividend for at least 10 years, which is a reliable track record.
NUW has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
NUW Yearly Dividends per shareNUW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
NUW Yearly Income VS Free CF VS DividendNUW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 20M -20M -40M

More info and screens

NUVEEN AMT-FREE MUNI VAL

NYSE:NUW (4/28/2025, 8:04:00 PM)

13.68

-0.03 (-0.22%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners40.19%
Inst Owner Change0.47%
Ins OwnersN/A
Ins Owner Change0%
Market Cap245.56M
Analysts0
Price TargetN/A
Short Float %0.14%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield 3.72%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years1
Div Non Decr Years1
Ex-Date04-15 2025-04-15 (0.0485)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 28.5
Fwd PE N/A
P/S 23
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)0.48
EY3.51%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.59
BVpS14.2
TBVpS14.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.35%
ROE 3.39%
ROCE 3.5%
ROIC 2.76%
ROICexc 2.78%
ROICexgc 2.78%
OM 84.12%
PM (TTM) 80.85%
GM 84.9%
FCFM N/A
ROA(3y)-2.87%
ROA(5y)0.77%
ROE(3y)-2.91%
ROE(5y)0.78%
ROIC(3y)2.43%
ROIC(5y)2.46%
ROICexc(3y)2.44%
ROICexc(5y)2.47%
ROICexgc(3y)2.44%
ROICexgc(5y)2.47%
ROCE(3y)3.08%
ROCE(5y)3.11%
ROICexcg growth 3Y7.27%
ROICexcg growth 5Y-3.9%
ROICexc growth 3Y7.28%
ROICexc growth 5Y-3.93%
OM growth 3Y1.21%
OM growth 5Y0%
PM growth 3Y7.8%
PM growth 5YN/A
GM growth 3Y0.51%
GM growth 5Y-0.16%
F-ScoreN/A
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 50.28
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.49%
EPS 3Y7.23%
EPS 5YN/A
EPS Q2Q%22.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.77%
Revenue growth 3Y4.79%
Revenue growth 5Y-3.52%
Sales Q2Q%5.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.67%
EBIT growth 3Y6.05%
EBIT growth 5Y-3.51%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A